Degos disease

Degos Disease, also known as Malignant Atrophic Papulosis, is a rare, chronic, vascular occlusive disorder that affects the skin, gastrointestinal tract, and, in some cases, multiple internal organs. The disease is characterized by the appearance of small, porcelain-white papules with a red rim, primarily on the trunk and upper extremities. These lesions represent infarcts of the skin due to the occlusion of small and medium-sized arteries. The exact cause of Degos Disease remains unknown, and it is classified into two forms: a benign form that affects only the skin, and a systemic form that involves internal organs and can be potentially life-threatening.

Symptoms and Signs

The initial presentation of Degos Disease typically involves the skin, where patients develop distinctive lesions that are small, round, and white with a telangiectatic rim. These lesions may appear over the trunk, arms, and occasionally on the face and scalp. In the systemic form of the disease, symptoms can vary widely depending on the organs involved but may include abdominal pain, diarrhea, weight loss, neurological symptoms (such as headaches, seizures, or sensory deficits), and cardiovascular symptoms.

Pathophysiology

The pathogenesis of Degos Disease is not fully understood, but it is believed to involve a combination of genetic predisposition and immune-mediated responses that lead to endothelial cell damage and thrombosis within small and medium-sized arteries. This results in tissue infarction and the characteristic lesions of the disease.

Diagnosis

Diagnosis of Degos Disease is primarily based on clinical presentation and histopathological examination of the lesions. Biopsy of a skin lesion typically shows wedge-shaped areas of ischemic necrosis and occlusive endovascular changes. Imaging studies and endoscopy may be used to assess internal organ involvement in systemic cases.

Treatment

There is no cure for Degos Disease, and treatment is largely supportive and aimed at managing symptoms. Antiplatelet agents and anticoagulants may be used to prevent thrombosis. Immunosuppressive therapy has been tried in some cases with variable success. The management of systemic involvement requires a multidisciplinary approach, addressing specific organ system complications as they arise.

Prognosis

The prognosis of Degos Disease varies. The benign cutaneous form may persist for years without significant progression, while the systemic form can lead to severe complications and is associated with a higher mortality rate, particularly if major organs are involved.

Epidemiology

Degos Disease is extremely rare, with only a few hundred cases reported in the medical literature. It can occur at any age but most commonly affects young adults. There is no known gender or racial predilection.

History

Degos Disease was first described in 1942 by Robert Degos, a French dermatologist. Since its initial description, the understanding of the disease has evolved, particularly regarding its systemic implications.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian